Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 370, Issue 1-3, 2010, Pages 79-86

  Cheow, Wean Sin ^a   Hadinoto, Kunn ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Biofilm; Emulsification; Encapsulation; Nanoparticle; Nanoprecipitation; Polymer

Indexed keywords

ANTIBIOTICS; BIOFILMS; BIOFILTERS; DRUG DOSAGE; EMULSIFICATION; LOADING; NANOPARTICLES; ORGANIC SOLVENTS; PHOSPHOLIPIDS; STANDARDS;

ANTI-BACTERIAL ACTIVITY; ANTI-BIOFILM; ANTIBIOTIC THERAPY; AQUEOUS PHASE; BI-PHASIC; BIOFILM INFECTIONS; DRUG LOADING; DRUG RELEASE; ENCAPSULATION EFFICIENCY; EVAPORATION METHOD; IN-VITRO; LEVOFLOXACIN; NANOPRECIPITATION; OIL PHASE; POLY(LACTIC-CO-GLYCOLIC ACID); PREPARATION METHOD; PRODUCTION YIELD; SOLID DOSAGE FORMS; SOLVENT-SOLUBLE; STANDARD METHOD;

ENCAPSULATION;

ANTIBIOTIC AGENT; LEVOFLOXACIN; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLYGLACTIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BIOFILM; DRUG RELEASE; ENCAPSULATION; FEASIBILITY STUDY; LUNG INFECTION; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 77957749362     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2010.08.050     Document Type: Article

References (22)

1. Rogueda P.G.A., Traini D. The nanoscale in pulmonary delivery. Part 2: Formulation platforms. Expert Opin. Drug Deliv. 2007, 4:607-620.
2. Pauwels P.R.A., Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364:613-620.
3. Suk J.S., Lai S.K., Wang Y.-Y., Ensign L.M., Zeitlin P.L., Boyle M.P., Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 2009, 30:2591-2597.
4. Meers P., Neville M., Malinin V., Scotto A.W., Sardaryan G., Kurumunda R., Mackinson C., James G., Fisher S., Perkins W.R. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 2008, 61:859-868.
5. Halwani M., Hebert S., Suntres Z.E., Lafrenie R.M., Azghani A.O., Omri A. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Int. J. Pharm. 2009, 373:141-146.
6. Rogueda P.G.A., Traini D. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects. Expert Opin. Drug Deliv. 2007, 4:595-606.
7. Hadinoto K., Cheow W.S. Hollow spherical nanoparticulate aggregates as potential ultrasound contrast agent: shell thickness characterization. Drug Dev. Ind. Pharm. 2009, 35:1167-1179.
8. Hadinoto K. Mechanical stability of hollow spherical nano-aggregates as ultrasound contrast agent. Int. J. Pharm. 2009, 374:153-161.
9. Ishida H., Ishida Y., Kurosaka Y., Otani T., Sato K., Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1998, 42:1641-1645.
10. Schwank S., Rajacic Z., Zimmerli W., Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 1998, 42:895-898.
11. Frick A., Möller H., Wirbitzki E. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. Eur. J. Pharm. Biopharm. 1998, 46:305-311.
12. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Controlled Release 1999, 57:171-185.
13. Barichello J.M., Morishita M., Takayama K., Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 1999, 25:471-476.
14. Peltonen L., Aitta J., Hyvönen S., Karjalainen M., Hirvonen J. Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles. AAPS PharmSciTech 2004, 5. [electronic resource].
15. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J.r., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Döring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation 2002, 109:317-325.
16. Harrison J., Ceri H., Yerly J., Stremick C., Hu Y., Martinuzzi R., Turner R. The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the calgary biofilm device. Biol. Proced. Online 2006, 8:194-215.
17. Cheow W., Chang M., Hadinoto K. Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm. Res. 2010, 27:1597-1609.
18. Zhang L., Chan J.M., Gu F.X., Rhee J.-W., Wang A.Z., Radovic-Moreno A.F., Alexis F., Langer R., Farokhzad O.C. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008, 2:1696-1702.
19. Lambert A., Regnouf-de-Vains J.-B., Ruiz-López M.F. Structure of levofloxacin in hydrophilic and hydrophobic media: Relationship to its antibacterial properties. Chem. Phys. Lett. 2007, 442:281-284.
20. Yang Y.-Y., Chung T.-S., Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22:231-241.
21. Mu L., Seow P.H., Ang S.N., Feng S.S. Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. Colloid Polym. Sci. 2004, 283:58-65.
22. Cohen-Sela E., Chorny M., Koroukhov N., Danenberg H.D., Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J. Controlled Release 2009, 133:90-95.